✦ LIBER ✦

Obinutuzumab (GA101) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Results From the Phase II GAUGUIN Study

✍ Scribed by Salles, G. A.; Morschhauser, F.; Solal-Celigny, P.; Thieblemont, C.; Lamy, T.; Tilly, H.; Gyan, E.; Lei, G.; Wenger, M.; Wassner-Fritsch, E.; Cartron, G.

Book ID: 121373842
Publisher: American Society of Clinical Oncology
Year: 2013
Tongue: English
Weight: 153 KB
Volume: 31
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2012.46.9718

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of obinutuzumab (GA101) in

Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma

✍ Ogura, Michinori; Tobinai, Kensei; Hatake, Kiyohiko; Uchida, Toshiki; Suzuki, Ta 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

A phase II study of Xcellerated T cells™

A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)

✍ J.G. Gribben; N.L. Bartlett; J.J. Stephenson; M.S. Milder; R.V. Boccia; C. Redfe 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Multicenter phase II study of bendamusti

Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

✍ Ken Ohmachi; Kiyoshi Ando; Michinori Ogura; Toshiki Uchida; Kuniaki Itoh; Nobuko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Bendamustine in Patients With Rituximab-

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

✍ Friedberg, J. W.; Cohen, P.; Chen, L.; Robinson, K. S.; Forero-Torres, A.; La Ca 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 118 KB

Phase II study of oral fludarabine in co

Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma

✍ Kensei Tobinai; Ken-ichi Ishizawa; Michinori Ogura; Kuniaki Itoh; Yasuo Morishim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 955 KB

A multicentre phase II clinical experien

A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma

✍ Owen A. O’Connor; Carol Portlock; Craig Moskowitz; David Straus; Paul Hamlin; Mi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB